ArkadiChinesMD

PubMed

• 4 citations
  Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment.
  Piet Geusens, Melissa Sam Bevers, Bert van Rietbergen, Osvaldo D Messina, Eric Lespessailles
  Journal of Bone and Mineral Research. 2022-06-01
• 10 citations
  Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years.
  Delphine Farlay, Sébastien Rizzo, David W Dempster, Shuang Huang, Arkadi Chines
  Journal of Bone and Mineral Research. 2022-05-01
• 7 citations
  The effect of denosumab and alendronate on trabecular plate and rod microstructure at the distal tibia and radius: A post-hoc HR-pQCT study.
  Yizhong Hu, Arkadi Chines, Yifei Shi, Ego Seeman, X. Edward Guo
  Bone. 2022-01-01

Journal Articles

• The Risk of Subsequent Osteoporotic Fractures Is Decreased in Subjects Experiencing Fracture While on Denosumab: Results from the FREEDOM and FREEDOM Extension Studies  
  Arkadi Chines, MD, Osteoporosis international

Other

• Chemical terrorism: Diagnosis and treatment of exposure to chemical weapons 
  Chines AA, Beary JF
  http://www.uptodate.com/contents/chemical-terrorism-diagnosis-and-treatment-of-exposure-to-chemical-
  UpToDate, Wolters Kluwer Health - 2013-02-11
• Osteogenesis imperfecta: Clinical features and diagnosis 
  Chines AA, Beary JF
  http://www.uptodate.com/contents/osteogenesis-imperfecta-clinical-features-and-diagnosis
  UpToDate, Wolters Kluwer Health - 2013-02-13
• Osteogenesis imperfecta: Management and prognosis 
  Chines AA, Beary JF
  http://www.uptodate.com/contents/osteogenesis-imperfecta-management-and-prognosis
  UpToDate, Wolters Kluwer Health - 2012-10-19